Evidence map›Paper›PMID 36301498›Full record

ArticleSub-cellular biochemistry2022

Epigenetic Reprogramming of the Glucose Metabolic Pathways by the Chromatin Effectors During Cancer.

Payel Mondal, Niharika Tiwary, Amrita Sengupta, Sinjini Dhang, Siddhartha Roy, Chandrima Das

Abstract read
PubMed Publisher
In one paragraph

Article in Sub-cellular biochemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Oncology letters · 2025
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Payel MondalBiophysics and Structural Genomics Division, Saha Institute of Nuclear Physics, Kolkata, India.
Niharika TiwaryBiophysics and Structural Genomics Division, Saha Institute of Nuclear Physics, Kolkata, India.
Amrita SenguptaBiophysics and Structural Genomics Division, Saha Institute of Nuclear Physics, Kolkata, India.
Sinjini DhangStructural Biology & Bio-Informatics Division, CSIR-Indian Institute of Chemical Biology, Kolkata, India.
Siddhartha RoyStructural Biology & Bio-Informatics Division, CSIR-Indian Institute of Chemical Biology, Kolkata, India.
Chandrima DasBiophysics and Structural Genomics Division, Saha Institute of Nuclear Physics, Kolkata, India. chandrima.das@saha.ac.in.
Homi Bhabha National Institute · INSaha Institute of Nuclear Physics · INAcademy of Scientific and Innovative Research · INIndian Institute of Chemical Biology · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glucose metabolism plays a vital role in regulating cellular homeostasis as it acts as the central axis for energy metabolism, alteration in which may lead to serious consequences like metabolic disorders to life-threatening diseases like cancer. Malignant cells, on the other hand, help in tumor progression through abrupt cell proliferation by adapting to the changed metabolic milieu. Metabolic intermediates also vary from normal cells to cancerous ones to help the tumor manifestation. However, metabolic reprogramming is an important phenomenon of cells through which they try to maintain the balance between normal and carcinogenic outcomes. In this process, transcription factors and chromatin modifiers play an essential role to modify the chromatin landscape of important genes related directly or indirectly to metabolism. Our chapter surmises the importance of glucose metabolism and the role of metabolic intermediates in the cell. Also, we summarize the influence of histone effectors in reprogramming the cancer cell metabolism. An interesting aspect of this chapter includes the detailed methods to detect the aberrant metabolic flux, which can be instrumental for the therapeutic regimen of cancer.

Indexed as

GlucoseNeoplasmsChromatinEpigenesis, GeneticGlycolysisHumansMetabolic Networks and PathwaysChromatinGlucoseEpigenetic readerExtracellular flux analysisGluconeogenesisGlucose metabolismGlycolysisHepatocellular carcinomaHistone modificationHypoxiaMetabolic intermediatesOXPHOSTCA cycleTechniques to measureWarburg effect

Identifiers

PMID36301498
OpenAlexW4307777300

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.